Suppr超能文献

一种设计对消除DNA结合的B-HLHZip蛋白起显性负效作用的通用方法。

A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding.

作者信息

Krylov D, Kasai K, Echlin D R, Taparowsky E J, Arnheiter H, Vinson C

机构信息

Laboratory of Biochemistry, National Cancer Institute, Building 37, Room 4D06, Bethesda, MD 20892, USA.

出版信息

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12274-9. doi: 10.1073/pnas.94.23.12274.

Abstract

We describe a method to design dominant-negative proteins (D-N) to the basic helix-loop-helix-leucine zipper (B-HLHZip) family of sequence-specific DNA binding transcription factors. The D-Ns specifically heterodimerize with the B-HLHZip dimerization domain of the transcription factors and abolish DNA binding in an equimolar competition. Thermal denaturation studies indicate that a heterodimer between a Myc B-HLHZip domain and a D-N consisting of a 12-amino acid sequence appended onto the Max dimerization domain (A-Max) is -6.3 kcal.mol-1 more stable than the Myc:Max heterodimer. One molar equivalent of A-Max can totally abolish the DNA binding activity of a Myc:Max heterodimer. This acidic extension also has been appended onto the dimerization domain of the B-HLHZip protein Mitf, a member of the transcription factor enhancer binding subfamily, to produce A-Mitf. The heterodimer between A-Mitf and the B-HLHZip domain of Mitf is -3.7 kcal.mol-1 more stable than the Mitf homodimer. Cell culture studies show that A-Mitf can inhibit Mitf-dependent transactivation both in acidic extension and in a dimerization-dependent manner. A-Max can inhibit Myc-dependent foci formation twice as well as the Max dimerization domain (HLHZip). This strategy of producing D-Ns may be applicable to other B-HLHZip or B-HLH proteins because it provides a method to inhibit the DNA binding of these transcription factors in a dimerization-specific manner.

摘要

我们描述了一种针对序列特异性DNA结合转录因子的碱性螺旋-环-螺旋-亮氨酸拉链(B-HLHZip)家族设计显性负性蛋白(D-N)的方法。这些D-N能与转录因子的B-HLHZip二聚化结构域特异性异源二聚化,并在等摩尔竞争中消除DNA结合。热变性研究表明,Myc B-HLHZip结构域与由附加在Max二聚化结构域上的12个氨基酸序列组成的D-N(A-Max)之间的异源二聚体比Myc:Max异源二聚体稳定-6.3千卡·摩尔-1。一摩尔当量的A-Max能完全消除Myc:Max异源二聚体的DNA结合活性。这种酸性延伸也已附加到转录因子增强子结合亚家族成员B-HLHZip蛋白Mitf的二聚化结构域上,以产生A-Mitf。A-Mitf与Mitf的B-HLHZip结构域之间的异源二聚体比Mitf同源二聚体稳定-3.7千卡·摩尔-1。细胞培养研究表明,A-Mitf能以酸性延伸和二聚化依赖的方式抑制Mitf依赖的反式激活。A-Max抑制Myc依赖的灶形成的能力是Max二聚化结构域(HLHZip)的两倍。产生D-N的这种策略可能适用于其他B-HLHZip或B-HLH蛋白,因为它提供了一种以二聚化特异性方式抑制这些转录因子DNA结合的方法。

相似文献

1
A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding.
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12274-9. doi: 10.1073/pnas.94.23.12274.
2
SREBP-1 dimerization specificity maps to both the helix-loop-helix and leucine zipper domains: use of a dominant negative.
J Biol Chem. 2004 Mar 19;279(12):11863-74. doi: 10.1074/jbc.M308000200. Epub 2003 Dec 31.
5
The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers.
Biochemistry. 1995 Oct 17;34(41):13554-64. doi: 10.1021/bi00041a035.
8
Design and properties of a Myc derivative that efficiently homodimerizes.
Oncogene. 1998 Nov 12;17(19):2463-72. doi: 10.1038/sj.onc.1202199.

引用本文的文献

1
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.
Mol Cancer. 2021 Jan 4;20(1):3. doi: 10.1186/s12943-020-01291-6.
2
Selective antagonism of cJun for cancer therapy.
J Exp Clin Cancer Res. 2020 Sep 11;39(1):184. doi: 10.1186/s13046-020-01686-9.
3
Optogenetic Inhibitor of the Transcription Factor CREB.
Chem Biol. 2015 Nov 19;22(11):1531-1539. doi: 10.1016/j.chembiol.2015.09.018.
7
Ectopic Mitf in the embryonic chick retina by co-transfection of β-catenin and Otx2.
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5328-35. doi: 10.1167/iovs.09-5015. Epub 2010 May 12.
8
Protein sequestration generates a flexible ultrasensitive response in a genetic network.
Mol Syst Biol. 2009;5:272. doi: 10.1038/msb.2009.30. Epub 2009 May 19.
9
Max-E47, a designed minimalist protein that targets the E-box DNA site in vivo and in vitro.
J Am Chem Soc. 2009 Jun 10;131(22):7839-48. doi: 10.1021/ja901306q.

本文引用的文献

1
A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis.
J Biol Chem. 1997 Jul 25;272(30):18586-94. doi: 10.1074/jbc.272.30.18586.
2
Proteins of the Myc network: essential regulators of cell growth and differentiation.
Adv Cancer Res. 1996;68:109-82. doi: 10.1016/s0065-230x(08)60353-x.
3
Dominant negative mutants of Myc inhibit cooperation of both Myc and adenovirus serotype-5 E1a with Ras.
J Cell Physiol. 1996 Apr;167(1):95-105. doi: 10.1002/(SICI)1097-4652(199604)167:1<95::AID-JCP11>3.0.CO;2-O.
4
5
Transcription factors 2: helix-loop-helix.
Protein Profile. 1994;1(6):635-709.
8
Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain.
Nature. 1993 May 6;363(6424):38-45. doi: 10.1038/363038a0.
9
A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2739-43. doi: 10.1073/pnas.90.7.2739.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验